Reports Q1 revenue $348.1M, consensus $345.44M. “Our strong financial and operational performance this quarter underscores the accelerating demand for our AI-driven diagnostic platform and the immense value of our multimodal data and corresponding AI models,” said Eric Lefkofsky, Founder and CEO of Tempus. “We continue to see strong momentum as we deploy more sophisticated algorithms across our platform, driving 36% revenue growth year-over-year, with particular strength in our Oncology diagnostic business and data and modeling business.”
Meet Samuel – Your Personal Investing Prophet
Double your TEM exposure with Tradr's TEMTPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- FDA turning to AI to speed up clinical trials, WSJ reports
- Tempus, USC announce strategic collaboration to accelerate precision medicine
- Tempus, Adobe, Helus, Constellation, Stryker Trending With Analysts
- Midday Fly By: BofA, Morgan Stanley beat expectations in Q1
- Tempus AI, Predicta Biosciences announces expansion of GenoPredicta